Trial intelligence / Profile preview

Lybrido and Lybridos for SSRI-associated Female Sexual Dysfunction (Phase 2, crossover)

2009-016790-15Phase 2Active

Sponsor
Emotional Brain
Start
Oct 2009
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial of sildenafil + testosterone and Lybridos in hypoactive sexual desire disorder (HSDD), Sexual Arousal Disorder and sexual dysfunction (3 arms), sponsored by Emotional Brain. Primary endpoint: Subjective sexual functioning. Started Oct 2009; status: active.

02

Drugs

sildenafil + testosteroneLybridos
03

Conditions

hypoactive sexual desire disorder (HSDD)Sexual Arousal Disordersexual dysfunction

Beyond the preview

Go deeper on 2009-016790-15.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2009-016790-15.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call